Search Results

been spokesman of the Research Training Group "Medicinal Chemistry of Selective GPCR Ligands" (GRK 1910

Chris Tate obtained his Ph.D. from the University of Bristol in 1989 and then moved to the University After obtaining a research fellowship at Girton College (Cambridge) he moved to the LMB in 1992 to work

Dmitry studied biophysics at the Moscow State University, followed by a PhD (1998) in protein folding

Before joining the Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000 , he researched at the Institute of Pharmacology Russian Academy of Medical Sciences in Moscow (1988- 1996). He received a Ph.D. in pharmacology in 1992 from the Russian Academy of Medical Sciences and an M.D. in 1988 from the Second Moscow Medical Institute, Moscow, Russia.

Born in 1984, he studied chemistry at the University of Erlangen-Nuremberg (2004–2010) and completed

University in Berlin/Germany and a Ph.D. in molecular pharmacology (supervisor: Bertil B Fredholm; 1998

the expectations by putting together an outstanding program with a special thought for Marc Caron (1946

Foord Steve Foord trained as a Physiologist and Pharmacologist and worked for Glaxo through to GSK from 1986

She received her BSc in Human Biology from King’s College London in 1997, and while her Ph.D. commenced

at the University of Chicago, he attended a NATO Advanced Study Institute in Les Houches, France in 1979

Mark Connor Undergraduate BSc with Honours in Pharmacology from University of Sydney (1987, snake neurotoxins ), Ph.D. from Department of Pharmacology, University of Washington (1992, mentor Charley Chavkin , sigma

Banks was an Assistant Professor in Analytical Chemistry at Concordia University, Montreal, Canada from 1994 to 1998.